Increased Levels of 16-Hydroxyestrone-Modified Proteins in Pregnancy and in Systemic Lupus Erythematosus*
RICHARD BUCALA,
ROBERT G. LAHITA,
JACK FISHMAN and
ANTHONY CERAMI
Laboratories of Medical Biochemistry, Immunology, and Biochemical Endocrinology, The Rockefeller University New York, New York 10021
Address all correspondence and requests for reprints to: Richard Bucala, Laboratory of Medical Biochemistry, Rockefeller University, Box 277, 1230 York Avenue, New York, New York 10021
The ketolic estrogen 16-hydroxyestrone (16OHE) reacts with lysineresidues, forming stable covalent adducts with proteins. Todetermine the extent of protein modification by 16OHE in vivo,we measured the level of 16OHElysine present within proteinsof varying half-lives obtained from normal subjects, patientswith systemic lupus erythematosus (SLE), and pregnant women.The latter groups have higher than normal levels of plasma 16OHE.The proteins analyzed were membrane proteins of the red celland the lymphocyte and basement membrane proteins of the glomerulus.We report that elevated levels of plasma 16OHE led to increasedformation of 16OHE-protein adducts and that the level of theseadducts increases with the half-life of the protein. In thecase of erythrocyte membrane proteins, pregnant women and womenwith SLE had significantly higher mean levels of 16OHE-lysinethan normal women (normal, 5.2 pmol 16OHE-lysine/mmol leucine;SLE, 15.7; pregnant, 24.9). A similar elevation in the modificationof lymphocyte proteins in women was found (normal, 15.6; SLE,40.5). Since the degree of protein modification also was dependenton the ambient level of free 16OUE, these measurements providea useful indicator of the long term 16aOHE status of an individual.The modification of proteins by 16OHE may be a link in the relationshipbetween female hormones, pregnancy, and systemic lupus erythematosus.
* This work was supported by the Kroc Foundation and Grant CA-22795.
Received August 30, 1984.
This article has been cited by other articles:
I Mendez, J Alcocer-Varela, A Parra, A Lava-Zavala, D A de la Cruz, D Alarcon-Segovia, and F Larrea Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin
Lupus,
January 1, 2004;
13(1):
45 - 53.
[Abstract][PDF]